|
Mochtar Riady Institute for Nanotechnology
With a population of over 220 Million, public health is
one serious concern in Indonesia. Cancer in particular is a leading
cause of deaths. Early diagnosis and effective treatment are keys
for the control and management of this complex systemic disease,
in which the research in Indonesia is still in its infancy.
As part of Lippo Medical and Health Program, that includes the
Faculty of Medicine Pelita Harapan University, Siloam Hospitals
and the Mochtar Riady Comprehensive Cancer Center (MRCCC), Mochtar
Riady Institute for Nanotechnology (MRIN) is established in 2006
to support cancer research in Indonesia using both genomic and proteomic
approaches.
Vision:
- To become an internationally recognized research center in
the field of nanomedicines focusing on oncology.
- To improve the nation's quality and competency in the field
of nanomedicines through quality education and scientific discovery.
- To foster research and education in the field on nanomedicines
through interdisciplinary research partnerships and collaborations
Mission:
To conduct innovative research on cancer prevention and new understandings
of the cause, early diagnosis, control and cure of cancer.
Lastest News
|
|
| |
|
- Andi Utama, Ph.D
Friday, Jun 11, 2010
Congratulation to Andi Utama, Ph.D and Team for the new publication in Liver International.
"Genotype diversity of hepatitis C virus (HCV) in HCV-associated liver disease patients in Indonesia"
Read More ... >>
|
Monday, May 3 , 2010
The Mochtar Riady Institute for Nanotechnology (MRIN) invites outstanding young Indonesians to apply for the MRIN Scholarship 2010 and pursue fulltime PhD-degree programs in cancer research
Read More ... >>
|
|
|
| Congratulations
to Prof. Dr. Susan Tai.
Friday,
September 11, 2009
For Prof. Tai’s unique contribution to the Universidad de Oriente,
Venezuela, with her creation of the Centre for Electron Microscopy
and later the Institute for Research in Biomedicine and Applied
Sciences (IIBCA), the University Council of the Universidad de Oriente
has recently honored her by changing the name of IIBCA to be Instituto
de Investigaciones en Biomedicina y Ciencias Aplicadas “Dr. Susan
Tai”. |
Publication -
Dr. rer. nat. Ivet Suriapranata
Friday, January 15, 2010
congratulations on the new publication from the Dr. rer. nat. Ivet Suriapranata.
"Alpha-fetoprotein gene polymorphisms and risk of HCC and Cirrhosis"
Go to Publication... >>
|
|
|
|
|
Job
Opportunity - RESEARCH ASSISTANTS
Friday,
September 11, 2009
to conduct research for genomic/ proteomic/ immunology related projects
under supervision of the laboratory principal investigator.
Minimum qualifications include a B.Sc. or M.Sc. in biology, chemistry,
biochemistry, pharmacy or a related field. Research experience is
preferred but not required.
Read
more... >>
|
|
| |